» Articles » PMID: 8620487

Cloning and Expression Analysis of Human Bleomycin Hydrolase, a Cysteine Proteinase Involved in Chemotherapy Resistance

Overview
Journal Cancer Res
Specialty Oncology
Date 1996 Apr 15
PMID 8620487
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

A cDNA encoding human bleomycin hydrolase, a member of the cysteine proteinase family of proteins, has been cloned from a human brain cDNA library. The isolated cDNA contains an open reading frame coding for a polypeptide of 456 amino acids that contains all of the structural features characteristic of cysteine proteinases, including the cysteine, histidine, and asparagine residues that are essential for the catalytic properties of these enzymes. The deduced amino acid sequence for human bleomycin hydrolase shows 92, 40, and about 35% of identities with those determined for rabbit bleomycin hydrolase, yeast bleomycin hydrolase, and bacterial aminopeptidase C, respectively. Northern blot analysis of poly(A)+ RNAs isolated from a variety of human tissues demonstrated that human bleomycin hydrolase is expressed in all examined tissues, which is consistent with a putative role of this protein as a proteolytic enzyme involved in norman cellular protein degradation and turnover. Preliminary expression analysis of bleomycin hydrolase in different human tumors showed increased expression of the enzyme in a series of head and neck carcinomas when compared with paired adjacent normal mucosa. We also observed a variable degree of bleomycin hydrolase expression in different types of lymphoma, with low or undetectable levels in Hodgkin's disease samples and higher levels in Burkitt's lymphomas. These results are consistent with a proposed role for human bleomycin hydrolase in resistance of some tumor to bleomycin chemotherapy.

Citing Articles

Pulmonary Toxicity of Hodgkin Lymphoma Treatment: A Prospective Single-Center Study.

Jona A, Miltenyi Z, Pinczes L, Kerek P, Bittner N, Szilasi M J Hematol. 2022; 10(6):266-273.

PMID: 35059088 PMC: 8734491. DOI: 10.14740/jh929.


Polyphosphate Reverses the Toxicity of the Quasi-Enzyme Bleomycin on Alveolar Endothelial Lung Cells In Vitro.

Muller W, Neufurth M, Wang S, Schroder H, Wang X Cancers (Basel). 2021; 13(4).

PMID: 33670189 PMC: 7916961. DOI: 10.3390/cancers13040750.


Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma.

Jona A, Miltenyi Z, Poliska S, Balint B, Illes A PLoS One. 2016; 11(6):e0157651.

PMID: 27327270 PMC: 4915614. DOI: 10.1371/journal.pone.0157651.


Mesenchymal stem cells are sensitive to bleomycin treatment.

Nicolay N, Ruhle A, Lopez Perez R, Trinh T, Sisombath S, Weber K Sci Rep. 2016; 6:26645.

PMID: 27215195 PMC: 4877675. DOI: 10.1038/srep26645.


A computational framework discovers new copy number variants with functional importance.

Banerjee S, Oldridge D, Poptsova M, Hussain W, Chakravarty D, Demichelis F PLoS One. 2011; 6(3):e17539.

PMID: 21479260 PMC: 3066184. DOI: 10.1371/journal.pone.0017539.